从微流体平台中的hiPSC产生的眼细胞前部段的生成
Gamze Koçak1,2, Sude Uyulgan1,2, Elifsu Polatlı1,2
1Izmir Biomedicine and Genome Center, Izmir, 35340, Türkiye.
Advanced biology
|April 19, 2024
概括
这项研究开发了一种微流体平台,用于将人类干细胞培养成眼前组织. 动态条件影响了细胞发育和基因表达,为视力恢复研究提供了新的见解.
科学领域:
- 眼科医生 眼科 眼科
- 再生医学是一种再生医学.
- 生物技术是生物技术.
背景情况:
- 眼科疾病导致显著的视力丧失和生活质量的降低.
- 前眼部分涉及近一半的视力障碍病例.
- 需要进行先进的眼科研究和针对前段的再生策略.
研究的目的:
- 创建一个微流体平台来研究人类诱导多能干细胞 (hiPSC) 衍生前眼部分段的发展.
- 为了研究空间机械反应条件对眼睛有机体形成的影响.
- 在动态培养环境下分析基因表达和细胞行为.
主要方法:
- 开发一个微流体平台,用于培养来自hiPSC的眼球器官.
- 在微流体芯片中实施各种细胞培养策略.
- 转录基因分析以确定机械反应基因.
- 对前眼细胞的分化协议的验证.
主要成果:
- 在动态培养下,hiPSC衍生细胞在mRNA和蛋白质水平上表现出眼前细胞特征.
- 根据分化和生长条件,YAP/TAZ和PIEZO1的表达有所不同.
- 代谢特征受到动态培养条件的影响.
结论:
- 微流体平台有效地支持来自hiPSCs的眼前组织的发展.
- 动态和机械反应条件在前眼发育中起着至关重要的作用.
- 这些发现为未来的前段再生和疾病建模研究提供了基础.
相关概念视频
iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
Induced Pluripotent Stem Cells
22.7K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
22.7K


